These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 373006

  • 21. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
    Smulevich AB, Minsker EI, Mazaeva NA, Volkova RP, Lukanina SK.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):912-20. PubMed ID: 5050051
    [No Abstract] [Full Text] [Related]

  • 22. Maintenance therapy and schizophrenia.
    Leff JP.
    Br J Psychiatry; 1975; Spec No 9():55-8. PubMed ID: 241453
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Experience with the depot neuroleptic LyogenR-depot].
    Bach O, Petermann H, Geppert V.
    Psychiatr Neurol Med Psychol (Leipz); 1978 Sep; 30(9):563-6. PubMed ID: 733993
    [Abstract] [Full Text] [Related]

  • 30. [Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
    Fünfgeld EW, Kulhanek F.
    Arzneimittelforschung; 1978 Sep; 28(9):1489-91. PubMed ID: 383096
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Evaluation of fluphenazine use since establishment of a psychiatric section].
    Roger BM.
    Ann Med Psychol (Paris); 1972 Apr; 1(4):550-5. PubMed ID: 4342755
    [No Abstract] [Full Text] [Related]

  • 33. Depot fluphenazine: risk/benefit ratio.
    Glazer WM.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [Abstract] [Full Text] [Related]

  • 34. Long-acting neuroleptics--a fairy story?
    Hiep A, Marriott P.
    Nurs Times; 1976 Jun; 72(22):863-6. PubMed ID: 775449
    [No Abstract] [Full Text] [Related]

  • 35. [Depot-neuroleptics in the treatment of schizophrenia].
    Schipper JA.
    Ned Tijdschr Geneeskd; 1971 Apr 17; 115(16):707-9. PubMed ID: 5551427
    [No Abstract] [Full Text] [Related]

  • 36. [Neuroleptic depot treatment of chronic psychoses with fluphenazine-dekanoate].
    Weiser G, Gattringer B, Bengesser G.
    Wien Med Wochenschr; 1973 Apr 07; 123(14):227-30. PubMed ID: 4695598
    [No Abstract] [Full Text] [Related]

  • 37. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
    DeWolfe AS, Barrell RP, London L, Spaner FE.
    Psychosomatics; 1971 Apr 07; 12(3):186-90. PubMed ID: 4950862
    [No Abstract] [Full Text] [Related]

  • 38. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ, Burnett GB, Nottingham JD, Sermas CE, Thornby JI.
    Curr Ther Res Clin Exp; 1976 Nov 07; 20(5):695-700. PubMed ID: 825356
    [No Abstract] [Full Text] [Related]

  • 39. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA, Aderounmu AF.
    J Clin Psychiatry; 1982 May 07; 43(5):195-6. PubMed ID: 7076630
    [Abstract] [Full Text] [Related]

  • 40. [Fluphenazine depot. The usefulness of neuroleptics in perspective].
    Malm U.
    Nord Psykiatr Tidsskr; 1971 May 07; 25(4):309-14. PubMed ID: 5154115
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.